top view blueberries with baby bottle fruits scaled

2026 Alert: New Regulations and Heavy Metal Findings in Infant Food. How Does Alianza’s Technology Respond?

The year 2026 has begun with a significant shake-up for the early nutrition industry. In January alone, U.S. state reports (such as the recent Florida report) revealed that 16 out of 24 infant formula samples analyzed contained concerning levels of heavy metals—including mercury, cadmium, arsenic, and lead—exceeding federal reference parameters.

This scenario coincides with the implementation, as of January 1, 2026, of pioneering legislation such as the Baby Food Protection Act (in states like Virginia and Illinois). These laws now require manufacturers to conduct monthly heavy metal testing and publicly report the results. Regulatory pressure from the FDA, under its “Closer to Zero” program, has placed a spotlight not only on agricultural origins but also on how processing can mitigate or exacerbate these risks.

4296

The Invisible Challenge: Process Contaminants

While heavy metals capture the headlines, the total safety of a formula also depends on controlling contaminants that arise during the refining of vegetable oils. Compounds such as 3-MCPD and Glycidyl Esters (GE) are now a top priority on global food safety agendas.

At Alianza, we have anticipated these challenges by developing cutting-edge technologies that guarantee cleaner and safer lipid solutions for the most vulnerable consumers.

Science and Purity: Our Value Proposition

To meet this high-demand environment, we offer solutions designed under the strictest analytical controls:

InfantFormula: Technical Purity and Contaminant Control

Our InfantFormula platform is a lipid blend optimized to drastically reduce process contaminants. Thanks to a state-of-the-art analytical infrastructure, we achieve safety levels that exceed market standards:

  • GE: < 0.05 ppm
  • 3-MCPD: < 0.25 ppm
  • MOAH/MOSH: < 1 ppm / < 8 ppm

This ensures a final product free of harmful chemical traces, aligned with the increasing regulatory demands of 2026.

FutureFirst: Mimetic and Functional Innovation

We don’t just eliminate the harmful; we enhance the essential. FutureFirst utilizes enzymatic interesterification to achieve a fatty acid profile enriched in sn-2 palmitate (35%), mimicking the structure of breast milk.

Key Benefits: It maximizes the absorption of fat-soluble vitamins and minerals, reduces the formation of calcium soaps (preventing constipation), and ensures greater energy intake for the baby’s muscular and skeletal development. All of this is guaranteed with Non-GMO raw materials and RSPO-certified palm oil.

  •  
bowl with puree baby

In a year where transparency and safety are the pillars of consumer trust, Alianza  reaffirms our commitment to providing ingredients that do more than just nourish—they protect the future.

Latest news

 

  • Virginia Department of Agriculture (VDACS): New Baby Food Testing and Labeling Law Effective Jan. 1, 2026.
  • Florida State Reports (January 2026): Heavy Metal Findings in Infant Formula Samples and State Lab Investigations.
  • FDA Human Foods Program (2026): Priority Deliverables for Reducing Contaminants in Childhood Nutrition.
  • Alianza Team Technical Data Sheet: FutureFirst & InfantFormula Solutions.
PRIVACY NOTICE

This website uses cookies so that we can offer you the best possible user experience. Cookie information is stored in your browser and performs functions such as recognizing when you return to our website or helping our team understand which sections of the website you find most interesting and useful.